References
- World Health Organization (WHO) WHO. Dementia; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia
- U.S. Department of Health and Human Services Cf, Disease Control and Prevention NCfH, statistics. CDC WONDER online database: about underlying cause of death, 1999-2020. 2019.
- Li X, Tsolis KC, Koper MJ, et al. Sequence of proteome profiles in preclinical and symptomatic Alzheimer’s disease. Alzheimers Dement. 2021;17(6):946–58.
- Van Acker ZP, Bretou M, Annaert W. Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors. Mol Neurodegener. 2019 Jun 3;14(1):20. doi: 10.1186/s13024-019-0323-7
- Kwart D, Gregg A, Scheckel C, et al. A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP beta-CTFs, not abeta. Neuron. 2019 Oct 23;104(2):256–270 e5. doi: 10.1016/j.neuron.2019.07.010
- Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018 Sep;17(9):660–688.
- Bai B, Vanderwall D, Li Y, et al. Proteomic landscape of Alzheimer’s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener. 2021 Aug 12;16(1):55. doi: 10.1186/s13024-021-00474-z
- Johnson ECB, Dammer EB, Duong DM, et al. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 May;26(5):769–780.
- Bai B, Wang X, Li Y, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer’s disease progression. Neuron. 2020 Mar 18;105(6):975–991 e7. doi: 10.1016/j.neuron.2019.12.015
- Inda MC, Joshi S, Wang T, et al. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction. Nat Commun. 2020 Jan 16;11(1):319. doi: 10.1038/s41467-019-14082-5
- Bourdenx M, Martin-Segura A, Scrivo A, et al. Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome. Cell. 2021 May 13;184(10):2696–2714 e25. doi: 10.1016/j.cell.2021.03.048
- Lee H, Aylward AJ, Pearse RV 2nd, et al. Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer’s disease risk gene SORL1. Cell Rep. 2023 Aug 29;42(8):112994. doi: 10.1016/j.celrep.2023.112994
- Essig DJ, Balboa JR, Stromgaard K. Development of peptide-based PDZ domain inhibitors. Methods Mol Biol. 2021;2256:157–177.
- Schiapparelli LM, Xie Y, Sharma P, et al. Activity-induced cortical glutamatergic neuron nascent proteins. J Neurosci. 2022 Oct 19;42(42):7900–7920. doi: 10.1523/JNEUROSCI.0707-22.2022
- Uezu A, Kanak DJ, Bradshaw TW, et al. Identification of an elaborate complex mediating postsynaptic inhibition. Science. 2016 Sep 9;353(6304):1123–1129. doi: 10.1126/science.aag0821